Click on the question to skip to your desired topic in the video.
Exploring the changing Talent Acquisition (TA) landscape and implications for an organisation’s current and future TA operations. We will focus in on a recent case study with a global specialty pharmaceutical company which highlights how TA can be disrupted and redefined to reflect the changing world that we now find ourselves in – and also importantly how this can be done in a way that reduces costs and adds real value to both the business and the individuals within it.
We are an internationally experienced team of Reimagineers, connected by a passion to help you transform your business for success. As a strategic partner in Talent Acquisition, we help you transform your model and processes to achieve your strategic objectives: whether it is recruiting for rapid growth, streamlining processes or achieving significant cost savings. We reinvent talent acquisition following our ReModel™ methodology. Let’s ReImagine, ReBuild, and ReStart together.
The Kyowa Kirin Group is a Japan-based pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. The Kyowa Kirin Group companies strive to contribute to the health and well-being of people around the world by creating new value through the pursuit of advances in life sciences and technologies. Our goal is clear: to do everything we can to answer the unmet medical needs of patients, their families, and medical professionals, and to do it as quickly as possible. Because every moment counts.
